COVID-19
Moderna up investments to produce 3 billion COVID vaccine doses in 2022
April 29, 2021COVID-19, Moderna, Vaccine, investment
Moderna have announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which …
Pharmafile.com’s weekly COVID-19 news round-up
April 28, 2021Research and Development COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news
The past week has seen plenty of COVID-19 news continue to roll in: The European Commission has sued AstraZeneca over …
COVID Symptom Study app reveals most common vaccine side effects
April 28, 2021Research and Development COVID-19, Vaccine, data
An analysis of over 600,000 people’s vaccine reports has been published in The Lancet Infectious Diseases journal, in the largest …
Single dose of COVID vaccine can cut transmissions in half
April 28, 2021Research and Development COVID-19, Public Health England, Vaccine
A Public Health England (PHE) study into the Pfizer-BioNTech and Oxford-AstraZeneca vaccines has found that a single dose of either …
European Commission sues AstraZeneca over COVID-19 jab supplies
April 27, 2021Manufacturing and Production AstraZeneca, AstraZeneca vaccine, COVID-19, EU, European Commission, covid 19 news, covid-19 news, european union, pharma, pharma news
The European Commission (EC) announced yesterday that it was suing AstraZeneca for failing to respect its contract to supply COVID-19 …
Phamafile.com’s top 10 news stories of the week
April 23, 2021Medical Communications COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma, pharma news
Among our top 10 stories this week: A study has found the Pfizer COVID-19 vaccine to have a significantly reduced …
Jubilant’s oral remdesivir formulation shows positive results in human trial
April 22, 2021COVID-19, Gilead, Jubilant Pharma, covid-19 treatment, pharma, pharma news, remdesivir
Jubilant Pharma has announced the successful completion of studies in human volunteers for their oral formulation of remdesivir – an …
UK Company launches COVID-19 neutralisation assay development kit
April 22, 2021COVID-19
The Native Antigen Company, a supplier of reagents for research into diagnostics and vaccines, have announced the launch of its …
Bharat Biotech jab shows 100% efficacy against severe COVID-19
April 22, 2021COVID-19, India
Indian biopharma company, Bharat Biotech, has reported interim analysis results from the Phase III trial of its COVID-19 vaccine, Covaxin, …
Pharmafile.com’s weekly COVID-19 news round-up
April 21, 2021Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news
The past week has seen lots of COVID-19 developments; Avacta’s 20-minute COVID test has gained clinical validation, the EMA has …
J&J COVID-19 vaccine to resume Europe rollout
April 21, 2021Research and Development COVID-19, COVID-19 vaccine, J&J, J&J vaccine, JJ, pharma, pharma news
The Johnson & Johnson COVID-19 vaccine will continue its rollout in Europe, following a review from the EMA.
UK Government launches COVID-19 Antivirals Taskforce
April 21, 2021Research and Development COVID-19, UK government
A new Antivirals Taskforce has been launched by the government to identify treatments for UK patients who have been exposed …
Adagio raises $336 million to advance COVID-19 antibody
April 20, 2021Manufacturing and Production Adagio, COVID-19, Financing, covid-19 treatment, pharma, pharma news
Adagio Therapeutics has financed $336 million to support the rapid advancement of their novel ADG20 antibody for the treatment and …
Avacta’s COVID-19 lateral flow test gains clinical validation
April 20, 2021Manufacturing and Production COVID-19
Avacta have announced positive data from the clinical validation of its AffiDX SARS-CoV-2 antigen lateral flow test, based on a …
Lilly’s COVID-19 drug has EUA revoked in favour of combination therapy
April 19, 2021Sales and Marketing COVID-19, Eli Lilly, FDA, covid-19 treatment, lilly, pharma, pharma news
The FDA have revoked Emergency Use Authorization (EUA) of Eli Lilly’s bamlanivimab drug for the treatment of COVID-19, per the …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
